Table 4.
Clinicopathological Features | Number (%) |
---|---|
Age at diagnosis | 35–90 years (Ø 65.7) |
Site | |
Tongue | 16 (27%) |
Floor of mouth | 15 (25%) |
Alveolar ridge upper and lower jaw | 14 (23%) |
Multifocal (2 or more localizations) | 10 (17%) |
Cheek mucosa | 3 (5%) |
Palate | 2 (3%) |
Sex | |
Male | 38 (63.3%) |
Female | 22 (36.7%) |
Nicotine | |
yes | 34 (56.7%) |
no | 7 (11.7%) |
not specified | 19 (31.7%) |
Alcohol | |
yes | 26 (43.3%) |
no | 2 (3.3%) |
not specified | 32 (53.3%) |
UICC stage | |
0 | 1 |
I | 8 |
II | 12 |
III | 11 |
IV a, b, c | 20 |
not specified | 8 |
T stage | |
Tis | 1 (1.7%) |
T1 | 16 (26.7%) |
T2 | 21 (35%) |
T3 | 6 (10%) |
T4 | 15 (25%) |
not specified | 1 (1.7%) |
Lymph node status | |
N0 | 27 (45%) |
N1 | 10 (16.7%) |
N2 a, b, c | 17 (28.3%) |
not specified | 6 (10%) |
Histological differentiation | |
G1 | 4 (7%) |
G2 | 38 (63%) |
G3 | 10 (17%) |
not specified | 8 (13%) |
Lymphovascular invasion | |
yes | 6 (10%) |
no | 41 (68.3%) |
not specified | 13 (21.7%) |
Recurrence | |
yes | 14 (23.3%) |
no | 35 (58.3%) |
lost follow-up | 7 (11.7%) |
died | 1 (1.7%) |
progression in palliative setting | 3 (5%) |